A new non-pharmacological vacuum therapy for female sexual dysfunction.

作者: Kevin L. Billups , Laura Berman , Jennifer Berman , Michael E. Metz , Margaret E. Glennon

DOI: 10.1080/713846826

关键词:

摘要: Although Female Sexual Dysfunction (FSD) affects 40% of American women, there is no FDA-approved pharmaceutical therapy. The EROS-CTD ™ (Clitoral Therapy Device, UroMetrics, Inc., St. Paul, MN) treatment the first FDA cleared-to-market therapy for FSD. Clitoral engorgement believed to play an important role in female sexual arousal and overall satisfaction. a small, battery-powered device designed enhance clitoral engorgement, increase blood flow clitoris, ultimately improve women with objective this study was assess effectiveness on (genital sensation, vaginal lubrication, ability reach orgasm, satisfaction) normal volunteers

参考文章(4)
Jennifer R. Berman, Irwin Goldstein, FEMALE SEXUAL DYSFUNCTION Urologic Clinics of North America. ,vol. 28, pp. 405- 416 ,(2001) , 10.1016/S0094-0143(05)70148-8
Jennifer R Berman, Laura Berman, Irwin Goldstein, Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology. ,vol. 54, pp. 385- 391 ,(1999) , 10.1016/S0090-4295(99)00230-7
K Park, I Goldstein, C Andry, MB Siroky, RJ Krane, KM Azadzoi, Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. International Journal of Impotence Research. ,vol. 9, pp. 27- 37 ,(1997) , 10.1038/SJ.IJIR.3900258
ROSEMARY BASSON, JENNIFER BERMAN, ARTHUR BURNETT, LEONARD DEROGATIS, DAVID FERGUSON, JEAN FOURCROY, IRWIN GOLDSTEIN, ALESSANDRA GRAZIOTTIN, JULIA HEIMAN, ELLEN LAAN, SANDRA LEIBLUM, HARIN PADMA-NATHAN, RAYMOND ROSEN, KATHLEEN SEGRAVES, R. TAYLOR SEGRAVES, RIDWAN SHABSIGH, MARCALEE SIPSKI, GORM WAGNER, BEVERLY WHIPPLE, REPORT OF THE INTERNATIONAL CONSENSUS DEVELOPMENT CONFERENCE ON FEMALE SEXUAL DYSFUNCTION: DEFINITIONS AND CLASSIFICATIONS The Journal of Urology. ,vol. 163, pp. 888- 893 ,(2000) , 10.1016/S0022-5347(05)67828-7